Showing 1121-1130 of 3031 results for "".
Filling the Gaps in the Multiple Sclerosis Treatment Landscape
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/filling-the-gaps-in-the-multiple-sclerosis-treatment-landscape/30372/The addition of a potential breakthrough agent may change the treatment arena, but wellness and early treatment remain the foundation of effective care.Stroke Busters: Mobile Stroke Units Offer a New Approach to Care
https://practicalneurology.com/diseases-diagnoses/imaging-testing/stroke-busters-mobile-stroke-units-offer-a-new-approach-to-care/30593/Calling 911 in Cleveland might deliver a highly specialized vehicle to suspected stroke patients. What's behind the new intervention?NEWS
https://practicalneurology.com/columns/practice-management/news/30702/- Turf Wars: Reports From the Front Linehttps://practicalneurology.com/columns/practice-management/turf-wars-reports-from-the-front-line/31111/In the October 2007 issue of Practical Neurology, Associate Editor Zac Haughn explores the complex landscape of professional conflicts and collaborations within the field of neurology. The article delves into the "turf wars" that arise when neurologists compete with other specialists, such as pulmon
News
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/news/30253/Lawful Physician-Hastened Death, Hearing Loss and Cognitive Impairment, Extended-Release Amantadine, Fibromyalgia Biomarkers, Phase 3 Trial of Rimegepant for Migraine, A Blood Test for Concussion, and more.Update in Epilepsy Therapeutics
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-in-epilepsy-therapeutics/30511/In addition to comorbid conditions and side effects, cost and availability should factor into therapeutic selection.Opportunities for Patients Arising From Practicalities of Health Care
https://practicalneurology.com/archives/2018-feb/opportunities-for-patients-arising-from-practicalities-of-health-care/30273/Telepresence in Neurology
https://practicalneurology.com/columns/practice-management/telepresence-in-neurology/30389/Delayed MS Drugs Awaits Decision at FDA
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/delayed-ms-drugs-awaits-decision-at-fda/30657/Pain and Gain: Reassessing Hydrocodone Prescribing
https://practicalneurology.com/diseases-diagnoses/headache-pain/pain-and-gain-reassessing-hydrocodone-prescribing/30742/New recommendations by an FDA committee aim to decrease opioid abuse, the group says, but will physicians and patients bear the burden of its effects?